Finalization of share buyback program in Initiator Pharma

Initiator Pharma A/S (“Initiator” or the “Company”) has today finalized the share buyback that was announced on 22 June 2022

Today Initiator has finalized the buyback of shares that was announced on 22 June 2022 and prolonged on 14 July 2022. In connection with the buy back, the Company has bought a total of 24,000 shares (“Treasury Shares”) at an average price of SEK 7.36.

Initiator has sold the Treasury Shares to certain members of the Board of Directors under the LTI2021-program. Each share was sold at a price of DKK 0.105 per share corresponding to par value.

The aggregate proceeds from the sale of treasury shares are DKK 2,520.